Radiology Journals

Radiology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kaira K et al. – The RD is the level 0 dose, and this regimen is a feasible and well–tolerated regimen for the treatment of patients with Stage III NSCLC.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address